Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This trial aims to determine whether Hou Gu Mi Xi is an effective treatment for improving symptoms and indicators in patients with spleen qi deficiency and radical gastrectomy for gastric cancer.
Epistemonikos ID: 295256bf7846077ca57e8242f21fa0fcfb58faaa
First added on: May 20, 2024